Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico

Eur Respir J. 2018 Mar 22;51(3):1702267. doi: 10.1183/13993003.02267-2017. Print 2018 Mar.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents*
  • Clinical Protocols
  • Humans
  • Mexico
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents